[Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension].
Angiotensin-converting enzyme (ACE) inhibitors have come into widespread use as a treatment option for patients with arterial hypertension, which fact can be explained by their apparent hypotensive effect, a small percent of side effects, protective effects on target organs, and a possibility of reversibility of essential hypertension- and symptomatic hypertensions-related changes in the cardiovascular system. There are a great many of drug preparations belonging in the group of ACE-inhibitors (capoten, enalapril, renitec (enalapril maleate), benazepril, quinapril, cilazopril, lizinopril, ramipril--to name but few of them. Specificities of different representatives of ACE-inhibitors, as to their clinical efficacy were found to be related to different pharmacokinetic properties of drugs.
Babadzhan
V D
VD
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000494:pharmacology; D000075202:Contraindications; D004359:Drug Therapy, Combination; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents
Ingibitory angiotenzinprevrashchaiushchego fermenta v lechenii arterial'noĭ gipertenzii.